Researchers from MIT have received an award of $82 million over 3 years from the Food & Drug Administration (FDA) Center for Biologics Evaluation & Research (CBER) Office to develop a fully integrated production line in a cGMP facility for the continuous manufacturing of mRNA therapeutics and cutting-edge mRNA research technologies. Read the MIT news article HERE!
